Abstract

Call for Abstract

OPEN

Abstract Submission
Open

Monday
October 1,
2025

DEADLINE

Abstract Submission
Deadline

Wednesday
December 31,
2025

Abstract Submission will be available from October 1, 2025.
Online Abstract Submission
( New Submission )

Please go to the Online Abstract Submission Form by clicking above.

View / Edit / Delete
( Submitted Abstract )

If you have already submitted your abstract, and would like to view, edit or delete the abstract, please go to the View/Edit/Delete page by clicking above.(Submission No. and Password are required to enter the page.)

Conditions for Submission Abstract

  • The Scientific Committee of APASL Oncology 2026 Tokyo will only accept original scientific material, which has not been published before. However, abstracts presented at local, regional or national meetings may be submitted.
  • Abstracts should be submitted in English.
  • The abstract is requested to start with the Background, continue with the Methods, Results, and finalized with the Conclusions.
  • The abstract must not exceed 250 words.
  • The category (one or two) defining the abstract must be chosen and marked on the form.
  • Preferred type of the presentation (oral, poster) must be marked on the form.
  • If there is any graphs, tables/statics or pictures, please send them to the congress secretariat info@apasl-oncology2026tokyo.org attached by jpg file, with your email subject as "figures for submission No. xxx (your submission no.)" after abstract online-submission has been completed.
  • Maximum size of any images is 1024 x 768 pixels.
  • Case report is acceptable.
  • The presenting author is required to complete conference pre-registration until February 27, 2026.

Categories

Call for Abstracts – APASL ONCOLOGY 2026 TOKYO

We are pleased to invite the submission of abstracts for APASL ONCOLOGY 2026 Tokyo, to be held on April 2–3, 2026, at The University of Tokyo, Ito International Research Center.

We welcome original and innovative research related to hepatocellular carcinoma (HCC), cholangiocarcinoma, metastatic liver tumors, and other liver-related malignancies, spanning clinical, translational, and basic science. Abstracts may include observational or interventional studies, cutting-edge therapies, and multidisciplinary approaches.

In addition to oral and poster sessions, special video sessions will showcase advanced interventional and surgical techniques, providing an opportunity for participants to share technical expertise and innovations.


Abstract Categories

1. Hepatocellular Carcinoma (HCC)

  • Epidemiology and Risk Factors
  • Biomarkers and Molecular Pathogenesis
  • Surveillance and Early Detection
  • Systemic Therapies (TKIs, ICIs, Combination Strategies)
  • Locoregional Therapies (TACE, TARE, HAIC, etc.)
  • Surgical Resection and Liver Transplantation
  • Outcomes and Prognostic Models

2. Cholangiocarcinoma and Biliary Tract Cancers

  • Epidemiology and Risk Factors
  • Molecular Classification and Targeted Therapy
  • Immunotherapy and Combination Strategies
  • Surgical Management and Transplantation
  • Endoscopic and Interventional Approaches
  • Locoregional and Radiation Therapies

3. Metastatic Liver Tumors

  • Colorectal Liver Metastases (CRLM)
  • Non-CRLM Metastases (Breast, Neuroendocrine, Others)
  • Surgical Strategies and Perioperative Management
  • Ablation, Embolization, and Radiation Techniques
  • Systemic Therapy and Multidisciplinary Management

4. Basic and Translational Research

  • Tumor Microenvironment
  • Genomics, Proteomics, and Liquid Biopsy
  • Animal Models and Preclinical Studies
  • Precision Medicine and Artificial Intelligence

5. Multidisciplinary and Supportive Care

  • Palliative Care and Quality of Life
  • Nutrition, Sarcopenia, and Metabolism
  • Patient-Reported Outcomes
  • Cost-Effectiveness and Health Policy

Video Sessions (Special Category)

Interventional Techniques in HCC

  • Radiofrequency Ablation (RFA)
  • Microwave Coagulation Therapy (MCT)
  • Transarterial Chemoembolization (TACE) / TARE
  • Radiation Therapy Techniques
  • Surgical Innovations (Resections, Transplant Procedures)

Endoscopic and Interventional Procedures in Cholangiocarcinoma

  • Biliary Drainage Techniques
  • Endoscopic Stenting
  • Advanced EUS-Guided Interventions

Awards

APASL ONCOLOGY 2026 Tokyo will recognize outstanding contributions through a series of prestigious awards:

  • Presidential Awards – for the best abstracts across all categories, presented during the Presidential Session.
  • Young Investigator Awards – to encourage promising young researchers, with recognition and partial travel/accommodation support.
  • Best Video Award – for the most innovative and technically outstanding video submission.

Awardees will be recognized during the congress and will receive official certificates.

Contact Information

If you have any question regarding abstract submission, please contact follows.
APASL Oncology 2026 Tokyo Congress Secretariat
c/o Academia Support Japan
info@apasl-oncology2026tokyo.org
+81-3-6380-0102 +81-3-6380-0103
Office Hours
9:30-17:30 except Saturdays, Sundays and National Holidays